Miraculins

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Miraculins today said that it has successfully completed a two-part ISO certification audit conducted by the BSI Group.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Miraculins yesterday said that it has received a C$1 million (US$986,000) non-convertible secured loan from Gretchen Ross.

The company said that if all warrants are exercised on or before expiration of the early exercise period, Miraculins expects to receive gross proceeds of around C$780,000.

Bloom Burton will provide financial modeling, an assessment of financing options, an evaluation of partnership opportunities, and other services.

The biomarker-based diagnostics firm sold 10.2 million units at C$.05 each.

The biomarker-based diagnostics firm will use the placement funding for R&D and corporate purposes.

Inverness, through its Biosite division, will develop and evaluate tests using Miraculins' panel of 35 biomarkers for placenta development and preeclampsia.

Miraculins will work with the Israel-based firm on a program to develop biomarker-based diagnostics for determining preeclampsia risk.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.